Sickle Cell Disease (SCD)

450 Words1 Page
bulb-icon

Recommended: Sickle cell anaemia abstract

Sickle Cell Disease (SCD) is genetic disorder1, affecting 100,000 individuals in the United States2, resulting from a single amino acid substitution3, which causes abnormality to hemoglobin; a protein contained in red blood cells (RBCs) 4.
Sickle Cell Disease, characterized by chronic inflammation and enhanced release of hemoglobin (Hb) 5, is a hemolytic disease6. Hemolysis, the rupture of red blood cells7, can occur either intravascularly or extravascularly8 and tends to occur more frequently in SCD patients9. Intravascular hemolysis releases free-plasma Hb10, which contains heme and is highly toxic when freely released into the body11. To maintain homeostasis and prevent toxic heme from being released, Haptoglobin (Hpt), a glycoprotein made …show more content…

Hemopexin (Hpx), produced by hepatic cells and also by other tissues (such as skin, lung, and kidney)18, is a heme-binding plasma glycoprotein19, which has the highest binding affinity to heme19. In the event of hemolytic anemia, Hpx immediately takes over the role of Hpt and continues to protect against toxic heme18. Furthermore, enzymes break down the Hb into heme, which instantly binds with Hpx. Afterwards, CD91/LRP-1 carries out the Hb and Hpx proteins to the liver20, where it gets secreted and is broken down to maintain homeostasis in the body. However, failure of Hpx binding to heme or Hpt binding to Hb consequently results in the release of toxic heme, which can cause chronic and acute effects on the liver, spleen, and kidney, as well as severe inflammation, cell injury, and oxidative damage21. The most effective treatment for resolving the imbalanced populations of Hpt and Hpx are transfusions every couple of weeks21. Healthy blood is supposed to enter the SCD blood and restore the Hpt and Hpx proteins and preserve homeostasis control, however previous research has yet to investigate the protein levels before and after transfusions through ELISAs. In some cases, SCD patients only receive transfusions every 6 months; they’re known as control SCD populations. Limited research has been done regarding Hpt and Hpx levels in control SCD populations,

Show More
Related

  • BioPure case

    1609 Words  | 4 Pages

    BioPure Corporation, which was founded in 1984 by entrepreneurs Carl Rausch and David Judelson, is a privately owned biopharmaceutical firm specializing in the ultra purification of proteins for human and veterinary use. In 1998 Biopure pioneered the development of oxygen therapeutics using “Hemoglobin”, a new class of pharmaceuticals that are intravenously administered to deliver oxygen to the body's tissues. Biopure's two products, Hemopure for human use, and Oxyglobin for animal veterinary use, both represented a new Oxygen based treatment approach for managing patients' oxygen requirements in a broad range of potential medical applications. The factor distinguishing Biopure’s two products from other blood substitute products being developed by two possible rivals, Baxter International and Northfeild Laboratories, is that its hemoglobin based source is bovine rather than human and was derived from the blood cells of cattle. Both of Biopure’s blood substitute products were in the final stages of the approval process of the Food and Drug Administration (FDA) in 1998. Oxyglobin had just received the FDA’s approval for commercial release declaring it safe and effective for medical use. Hemopure was entering final Phase 3 clinical trials and was optimistically expected to see final FDA approval for release in 1999. The FDA approval of Oxyglobin and its possible subsequent release into the veterinary market caused concern over whether the early release of Hemoglobin would impinge BioPure’s ability to price Hemopure when the product finally received approval. Given that the two products were almost identical in properties and function, it was thought that the early release of Oxyglobin would create an unrealistic price expectation for Hemopure if released first.

    Read More

  • Chronic Wasting Disease (CWD)

    1090 Words  | 3 Pages

    Chronic Wasting Disease (CWD) is a fatal neuro-degenerative, transmissible spongiform encephalopathy (TSE) of the family Cervidae (Hamir, et.al., 2006). The family Cervidae includes mule deer, Odocolileus hemionus, white-tailed deer, Odocolileus virginianus, Rocky Mountain elk, Cervus elaphus nelsoni, and moose, Alces alces shirasi, among others (Sigurdon & Aguzzi, 2007). CWD is a prion disease, meaning it is a protein caused infection, that occurs naturally in the deer family (Song & Lawson, 2009). This protein is suspected to be an abnormal isoform (PrPSc) of the naturally occurring host prion protein (PrPC) (Blanchong, et. Al., 2009). Bovine spongiform encephalopathy (BSE), mad cow disease, is a similar prion effecting cattle as CWD affects Cervidae. Although, scientists are not sure of transmission route it is suspected that CWD is transmissible and infectious through direct contact with infected individuals or through environmental contamination (Song & Lawson, 2009). Tests have been performed showing susceptibility of altered mice to oral transmission, mimicking the suspected route of entry, and the incubation appears slower but lasts longer with oral infection (Trifilo, et.al., 2007). The approximate time from the initial infection to death is three years.

    Read More

  • Erythropoiin Essay

    682 Words  | 2 Pages

    To help people with chronic anemia a synthetic version of Erythropoietin was produced called r-HuEPO, while provin...

    Read More

  • Sickle Cell Disease Case Study

    878 Words  | 2 Pages

    1. Sickle Cell Disease is life-threatening and has a risk of of causing depression. In this study I examine the experiences that Sickle Cell patients go through specifically at emergency healthcare facilities to find out if there are any negative stigmatizations surrounding this disease. There may be judgments that are made about these patients from healthcare professionals when they seek drugs for their pain relief that may cause the stigmatization to occur. I will also investigate why individuals that have Sickle Cell Disease experience longer waiting times at emergency healthcare facilities and the lack of control they may have over their care regime.

    Read More

  • Hemophilia Research Paper

    881 Words  | 2 Pages

    Hemophilia is a rare bleeding disorder that slows the blood clotting process, which is not normal. Some people with Hemophilia may just have a little bit of “clotting factor” or no clotting factor at all (National Institute of Health [NIH], 2013). Clotting factor is a protein in blood that controls bleeding and they are needed the blood to clot normally. In order to help the blood clot, clotting factors work with “platelets” (National Institute of Health [NIH], 2013). Platelets are small blood cell fragments that form in the bone marrow, a tissue in the bones that is similar to a sponge. The functions of platelets have a very important role in blood clotting; the role of a platelet is to stick together (by the help of clotting factors) to block cuts, break on the carriers of blood (veins or arteries) throughout the body, and stop the bleeding when “blood vessels” (National Institutes of Health [NIH], 2013) are injured. Blood vessels are tube like structures carrying blood through the tissues and organs, like a vein, artery, or capillary. People with hemophilia do not have enough “clotting factor VIII or IX” (World Federation of Hemophilia [WFH], 2013) in their blood, which results to prolonged bleeding or oozing, meaning that bleeding can last longer (though, not faster) than usual after surgeries, accidents, or having teeth pulled out at the dentist. Clotting factor VIII, which can also be called as “anti-hemophilic factor” (AHF, for short) (Patient.co.uk, 2011), is a blood clotting protein that is necessary for humans to have. Clotting Factor IX is a protein that i...

    Read More

  • Sickle Cell Case Study

    1537 Words  | 4 Pages

    What is Sickle cell disease? Sickle cell affects a disease; that disease is called which affects the hemoglobin when the red blood cells that send oxygen through the body are killed off and weakened. Sickle cells can be found in every 1 and 1000 African Americans, it is affecting about 70,000 to 80,000 Americans in the United States. Sickle cell is a death threatening disease, and the severity of symptoms can vary from person to person (Sickle cell disease (SCD), 2015). Some people have light conditions, but others can have severe conditions, which, mean they could be hospitalized. Characteristics of this disease are caused by a minimum of low blood cells, which is called anemia.

    Read More

  • Sickle Cell Anemia Essay

    944 Words  | 2 Pages

    Sickle cell anemia is a genetic disorder that erythrocytes tolerate sickle shape red blood cells. These red blood cells are easy to damage, which leads to hemolytic anemia. Abnormal hemoglobin is fragile to low oxygen conditions within the body. It loses the blood solubility, and then forms thick strands called polymers. This gives the abnormal shape, called Sickle cell.

    Read More

  • Sickle Cell Anemia

    1107 Words  | 3 Pages

    Sickle cell anemia is a blood disorder that affects hemoglobin (pronounced: hee-muh-glow-bin), a protein found in red blood cells that helps carry oxygen throughout the body.

    Read More

  • Funding of sickle cell diseases because of Race.

    789 Words  | 2 Pages

    “In the United States, it's estimated that sickle cell anemia affects 70,000–100,000 people, mainly African Americans” (NHLBI, NIH, Who is at risk for sickle cell anemia). SCD is a disease that is a serious disorder in which the body can make normal blood cells and sickle shape cells. Sickle shape cells can block the blood flow in your vessels and cause pain or organ damage also put you in risk for infections. SCD has no cure available but there are many treatments out there to deal with the complications of it. From over years treatments did get better from way back in the day doctors have learned. Sickle cell disease has lack of attention and funding because it’s only affecting African American the most.

    Read More

  • Sickle Cell Anemia

    791 Words  | 2 Pages

    Sickle cell anemia is an inherited disease of red blood cells. Normally red blood cells contain a protein called hemoglobin A, which carries oxygen to all the organs in the body. With sickle cell anemia, however, the body makes a different kind of protein, called hemoglobin S.

    Read More

  • Sickle Cell Anemia

    631 Words  | 2 Pages

    Sickle cell anemia is a genetic disorder. For a person to have sickle cell anemia they must have received two copies of the gene, one from each parent. A person with the sickle cell trait only received one sickle cell gene and a normal hemoglobin gene. People who have the sickle cell trait do not develop sickle cell anemia however they can pass the deformed gene on to their children. People with just the trait do not face the complications caused by the disorder.

    Read More

  • Analysis Of Sickle Cell Anemia

    986 Words  | 2 Pages

    Sickle Cell Anemia is an inherited blood disorder that is extremely challenging to live with. Its symptoms are many, with the most prominent being severe pain that can become unbearable to the point where hospitalization is required. Because sickle cell is a genetic disorder, a person is born with it and it is usually permanent. Unfortunately, there are risks and complications associated with this disease. However there are various treatment options for a patient with sickle cell and also support to help people understand and cope with this challenging disease.

    Read More

  • Function and Structure of Hemoglobin and Myoglobin

    829 Words  | 2 Pages

    Sickle cell anemia is the most common in hemoglobin mutation diseases due to mutation to beta-blobin gene. The substitution of valine for glutamate at position 6 of the beta chains paces a nonpolar residue on the outside of hemoglobin S. the oxygen affinity and allosteric properties of hemoglubin are virtually unaffected by this changes. However, this alternation markedly reduces the solubility of the deoxygenated but not the oxygenated form of hemoglobin. Thus, sicking occurs when there is a high concentration of the deoxygenated form of hemoglobin.

    Read More

  • Cirrhosis Essay

    3222 Words  | 7 Pages

    The liver plays central role in each of these phases of clotting process, as it synthesizes the majority of coagulation factors and proteins involved in fibrinolysis as well as thrombopoietin., which is responsible for platelet production from megakaryocytes. In cirrhosis, liver is badly get damaged. So the production of coagulation factors and proteins is impaired. Many pathological processes associated with cirrhosis, such as portal hypertension and endothelial dysfunction as well as co-morbid conditions, may also alter the coagulation process. Consequently, patients with liver disease as in cirrhosis, have a disturbed balance of procoagulant and anti- coagulant factors which deviates from the normal coagulation cascade.

    Read More

  • Ethical Concerns in Gene Therapy Incorporation

    917 Words  | 2 Pages

    Individuals who inherited this disease from their parents do not possess the standard hemoglobin that should be contained in RBC. Hemoglobin is a protein present in RBC, which transports oxygen to all parts of the body (National Heart and Blood Institute, 2017). The disease which impairs the hemoglobin’s responsibility, prevents blood cells from receiving the sufficient oxygen, causes RBC to be sickle shaped. Sickle cell disease precedes to several painful health complications such as VOC (vaso- occlusive crises), which are severe pain recurring episodes, that can lead to irreversible organ damage. Sickle cell anemia causes red blood cells to hemolyze continuously through an individual’s lifetime… hemolysis is the breakdown of red blood cells (Krishnamoorthy, et al. 2017). An experimental study was conducted with SCD Townes mice to test a possible solution for sickle cell anemia. Throughout a seven-week span, mice orally conveyed dosages of 100 mg/kg of DMF. DMF known as dimethyl fumarate is small complex molecule and which binds and activates to enhance Nrf2 to enhance Hbf. “Nrf2 is a transcription factor that triggers cytoprotective and antioxidant pathways to limit oxidative damage, inflammation, and increases HbF” (Krishnamoorthy, et al. 2017). Fetal hemoglobin (Hbf) is the hemoglobin present in fetuses; it is responsible for the transportation of oxygen

    Read More

More about Sickle Cell Disease (SCD)

Open Document